Target Name: LOC105372912
NCBI ID: G105372912
Review Report on LOC105372912 Target / Biomarker Content of Review Report on LOC105372912 Target / Biomarker
LOC105372912
Other Name(s): LOC105372912 variant X1 | Uncharacterized LOC105372912, transcript variant X1

Unlocking the Potential of LOC105372912: A Potential Drug Target and Biomarker

LOC105372912 is a gene that has garnered significant attention due to its unique genetic variation. It has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. In this article, we will explore the science behind LOC105372912 and its potential as a drug target and biomarker.

The LOC105372912 Mutation

LOC105372912 is a single-nucleotide polymorphism (SNP) that has been identified in various populations. It is a missense SNP, which means that a change in the nucleotide base from A to T or vice versa can lead to a change in the amino acid sequence of the protein it codes for. The LOC105372912 SNP has been implicated in various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions.

Potential Drug Target

LOC105372912 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with disease. One of the most promising aspects of LOC105372912 is its role in cell signaling pathways, including the NF-kappa pathway. This pathway is involved in various cellular processes, including cell growth, differentiation, and survival.

Research has shown that LOC105372912 variants are associated with increased NF-kappa activity, which can lead to the development of various diseases, including cancer. Therefore, targeting LOC105372912 may provide new insights into the mechanisms underlying these diseases and may potentially lead to the development of new treatments.

Biomarker Potential

LOC105372912 has also been identified as a potential biomarker for various diseases. The LOC105372912 gene has been shown to be involved in various cellular processes that are associated with disease. For example, LOC105372912 has been associated with increased NF-kappa activity, which is a known risk factor for the development of neurodegenerative disorders.

In addition, LOC105372912 variants have also been associated with increased risk of certain psychiatric conditions, including depression and anxiety. This suggests that LOC105372912 may play a role in the development of these conditions. Therefore, LOC105372912 may be a valuable biomarker for the diagnosis and treatment of psychiatric conditions.

Conclusion

LOC105372912 is a gene that has garnered significant attention due to its unique genetic variation. Its potential as a drug target and biomarker for various diseases makes it an exciting area of research. As further studies continue to investigate the role of LOC105372912, we may gain new insights into the underlying mechanisms of various diseases and develop new treatments.

Targeting LOC105372912 may provide new avenues for research into the development of new treatments for a variety of diseases. Additionally, its potential as a biomarker may have the potential to revolutionize the field of psychiatric medicine. As research continues to advance, we can look forward to the development of new treatments and insights into the science behind LOC105372912.

Protein Name: Uncharacterized LOC105372912, Transcript Variant X1

The "LOC105372912 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372912 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265